• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[头颈部癌症鳞状细胞癌中的半乳糖凝集素]

[Galectins in squamous cell carcinomas of the head and neck cancers].

作者信息

Cada Z, Plzák J, Chovanec M, Dvoránková B, Lacina L, Szabó P, Smetana K, Betka J

机构信息

Karlova Univerzita, 1. lékarská fakulta, Anatomický ústav, Praha.

出版信息

Cas Lek Cesk. 2008;147(11):559-63.

PMID:19097359
Abstract

Cancers of head and neck represents about 5% of all tumors. 80 to 90% of these tumors are constituted of squamous cell carcinomas. Despite a rapid progress in diagnostics and therapy the overall 5-year survival of this type of cancer is among the lowest of the major cancer types. This unfavourable situation needs the extensive research to found new markers to better characterize biological behavior of tumors as a rational background for more sophisticated therapeutic modalities. Among the most promising markers are endogenous lectins called galectins and their ligands. Especially galectin-1, -3 and -7 play a key role in pathology of squamous cell carcinomas.

摘要

头颈部癌症约占所有肿瘤的5%。这些肿瘤中80%至90%由鳞状细胞癌构成。尽管在诊断和治疗方面取得了快速进展,但这类癌症的总体5年生存率在主要癌症类型中是最低的之一。这种不利情况需要进行广泛研究以找到新的标志物,从而更好地表征肿瘤的生物学行为,为更复杂的治疗方式提供合理依据。最有前景的标志物之一是内源性凝集素,即半乳糖凝集素及其配体。特别是半乳糖凝集素-1、-3和-7在鳞状细胞癌的病理过程中起关键作用。

相似文献

1
[Galectins in squamous cell carcinomas of the head and neck cancers].[头颈部癌症鳞状细胞癌中的半乳糖凝集素]
Cas Lek Cesk. 2008;147(11):559-63.
2
Detection of new diagnostic markers in pathology by focus on growth-regulatory endogenous lectins. The case study of galectin-7 in squamous epithelia.
Prague Med Rep. 2005;106(2):209-16.
3
Expression of galectins in head and neck squamous cell carcinoma.半乳糖凝集素在头颈部鳞状细胞癌中的表达
Head Neck. 1996 Sep-Oct;18(5):422-32. doi: 10.1002/(SICI)1097-0347(199609/10)18:5<422::AID-HED5>3.0.CO;2-7.
4
Galectin-3, an endogenous lectin, as a tool for monitoring cell differentiation in head and neck carcinomas with implications for lectin-glycan functionality.半乳糖凝集素-3,一种内源性凝集素,作为监测头颈癌细胞分化的工具及其对凝集素-聚糖功能的影响。
Acta Otolaryngol. 2003 Jan;123(2):261-3.
5
Galectins as modulators of tumor progression in head and neck squamous cell carcinomas.半乳糖凝集素作为头颈部鳞状细胞癌肿瘤进展的调节因子
Head Neck. 2007 Sep;29(9):874-84. doi: 10.1002/hed.20559.
6
[The effect of the microenvironment of head and neck cancers on tumor progression].[头颈部癌症的微环境对肿瘤进展的影响]
Magy Onkol. 2009 Mar;53(1):51-9. doi: 10.1556/MOnkol.53.2009.1.8.
7
Role of molecular markers and gene profiling in head and neck cancers.分子标志物和基因谱在头颈癌中的作用。
Curr Opin Oncol. 2009 May;21(3):206-11. doi: 10.1097/CCO.0b013e328329ac00.
8
The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy.检测头颈部鳞状细胞癌(HNSCC)患者循环中半乳糖凝集素-1和-3的水平可用于监测肿瘤进展和/或治疗反应。
Oral Oncol. 2008 Jan;44(1):86-93. doi: 10.1016/j.oraloncology.2006.12.014. Epub 2007 Mar 9.
9
Role of molecular markers in the management of head and neck cancers.分子标志物在头颈部癌症管理中的作用。
Curr Opin Oncol. 2011 May;23(3):259-64. doi: 10.1097/CCO.0b013e328344f53a.
10
Galectin-3 - an emerging prognostic indicator in advanced head and neck carcinoma.
Eur J Cancer. 2004 Oct;40(15):2324-30. doi: 10.1016/j.ejca.2004.06.025.